ALEMBIC PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

12 Jul 2024

Alembic Pharmaceuticals receives USFDA Tentative Approval for Selexipag for Injection, 1,800 mcg/vial.

Source: BSE India

View all announcements for ALEMBIC PHARMACEUTICALS LTD.